Abstract:Metabolic reprogramming has been coined as a hallmark of cancer, accompanied by which the alterations in metabolite levels have profound effects on gene expression, cellular differentiation, and the tumor environment. Yet a systematic evaluation of quenching and extraction procedures for quantitative metabolome profiling of tumor cells is currently lacking. To achieve this, this study is aimed at establishing an unbiased and leakage-free metabolome preparation protocol for HeLa carcinoma cell. We evaluated 12 combinations of quenching and extraction methods from three quenchers (liquid nitrogen, -40 degrees C 50% methanol, 0.5 degrees C normal saline) and four extractants (-80 degrees C 80% methanol, 0.5 degrees C methanol/chloroform/water [1:1:1 v/v/v], 0.5 degrees C 50% acetonitrile, 75 degrees C 70% ethanol) for global metabolite profiling of adherent HeLa carcinoma cells. Based on the isotope dilution mass spectrometry (IDMS) method, gas/liquid chromatography in tandem with mass spectrometry was used to quantitatively determine 43 metabolites including sugar phosphates, organic acids, amino acids (AAs), adenosine nucleotides, and coenzymes involved in central carbon metabolism. The results showed that the total amount of the intracellular metabolites in cell extracts obtained using different sample preparation procedures with the IDMS method ranged from 21.51 to 295.33 nmol per million cells. Among 12 combinations, cells that washed twice with phosphate buffered saline (PBS), quenched with liquid nitrogen, and then extracted with 50% acetonitrile were found to be the most optimal method to acquire intracellular metabolites with high efficiency of metabolic arrest and minimal loss during sample preparation. In addition, the same conclusion was drawn as these 12 combinations were applied to obtain quantitative metabolome data from three-dimensional (3D) tumor spheroids. Furthermore, a case study was carried out to evaluate the effect of doxorubicin (DOX) on both adherent cells and 3D tumor spheroids using quantitative metabolite profiling. Pathway enrichment analysis using targeted metabolomics data showed that DOX exposure would significantly affect AA metabolism-related pathways, which might be related to the mitigation of redox stress. Strikingly, our data suggested that compared to two-dimensional (2D) cells the increased intracellular glutamine level in 3D cells benefited replenishing the tricarboxylic acid (TCA) cycle when the glycolysis was limited after dosing with DOX. Taken together, this study provides a well-established quenching and extraction protocol for quantitative metabolome profiling of HeLa carcinoma cell under 2D and 3D cell culture conditions. Based on this, quantitative time-resolved metabolite data can serve to the generation of hypotheses on metabolic reprogramming to reveal its important role in tumor development and treatment.

A systematic evaluation of quenching and extraction procedures for quantitative metabolome profiling of HeLa carcinoma cell under 2D and 3D cell culture conditions

Optimization of metabolomics pretreatment method of cholangiocarcinoma cells based on ultrahigh performance liquid chromatography coupled with mass spectrometry

A Quantitative Metabolomics Assay Targeting 14 Intracellular Metabolites Associated with the Methionine Transsulfuration Pathway Using LC–MS/MS in Breast Cancer Cells

A systematic evaluation of quenching, extraction and analysis procedures for metabolomics study of the mechanism of QYSLD intervention in A549 cells

A Simultaneously Quantitative Method to Profiling Twenty Endogenous Nucleosides and Nucleotides in Cancer Cells Using UHPLC-MS/MS.

Liquid chromatography coupled to high-resolution mass spectrometry metabolomics: A useful tool for investigating tumor secretome based on a three-dimensional co-culture model

Development of methionine methylation profiling and relative quantification in human breast cancer cells based on metabolic stable isotope labeling.

Impact of sample preparation upon intracellular metabolite measurements in 3D cell culture systems

Biotransformation-based Metabolomics Profiling Method for Determining and Quantitating Cancer-Related Metabolites.

Metabonomic study on the antitumor effect of flavonoid derivative 3d in HepG2 cells and its action mechanism.

Isolation and Metabolic Assessment of Cancer Cell Mitochondria

The Measurement and Analysis of Impedance Response of HeLa Cells to Distinct Chemotherapy Drugs

In-depth organic mass cytometry reveals differential contents of 3-hydroxybutanoic acid at the single-cell level

Metabolic Drug Response Phenotyping in Colorectal Cancer Organoids by LC-QTOF-MS

Optimization of Lipid Extraction and Analytical Protocols for UHPLC-ESI-HRMS-based Lipidomic Analysis of Adherent Mammalian Cancer Cells

Qualitative and quantitative analysis of tumor cell metabolism via stable isotope labeling assisted microfluidic chip electrospray ionization mass spectrometry.

Validation of Metabolic Alterations in Microscale Cell Culture Lysates Using Hydrophilic Interaction Liquid Chromatography (HILIC)-Tandem Mass Spectrometry-Based Metabolomics

Development of a Data-Independent Targeted Metabolomics Method for Relative Quantification Using Liquid Chromatography Coupled with Tandem Mass Spectrometry.

Untargeted Metabolite Mapping in 3D Cell Culture Models Using High Spectral Resolution FT-ICR Mass Spectrometry Imaging

Enhanced Lipidomics Analysis of Breast Cancer Cells Using Three‐phase Liquid Extraction and Ultra High‐performance Liquid Chromatography Coupled With Quadrupole Time‐of‐Flight Tandem Mass Spectrometry

Multi-omics Analysis Defines 5-Fluorouracil Drug Resistance in 3D HeLa Carcinoma Cell Model